Weekly Digest – October 2025 Weekly Digest – October 2025 15 October 2025: Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio Boehringer Ingelheim and AimedBio have entered a global collaboration and licensing agreement to co-develop a novel antibody-drug conjugate […]